Signia Therapeutics is pleased to announce that it will have several activities during the BIO 2018 that will be held in Boston from June 4 to June 7 2018. As the world’s largest biotechnology event, the BIO International Convention provides several specialized opportunities geared towards start-up and emerging companies.
Signia Therapeutics has been selected to present during the Start-Up Stadium which is designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, and BIO attendees. The presentation will be on June 6 at 12:00. The company will also be present in the French Pavilion as a member of Lyon BioPôle, the 2nd largest Bio-Cluster in France. Finally, Michel Cousineau, the President of Signia Therapeutics, will take part to the Partnering Forum to engage discussions with potential partners.